Get started
Author

Evelyn Mei Ling Goh

Observed names: E. Goh, Evelyn Goh
ORCID: 0000-0002-2115-3423
Observed ORCID: 0000-0002-2115-3423
OpenAlex ID: A5068401803
Development and validation of high‐performance liquid chromatography–tandem mass spectrometry assay for 6‐(3‐benzoyl‐ureido)‐hexanoic acid hydroxyamide, a novel HDAC inhibitor, in mouse plasma for pharmacokinetic studies
2007 · Pauline Yeo, Liu Xin, et al. · Biomedical Chromatography · 39
Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse
2021 · Chi Hon Sia, Ziteng Wang, et al. · Clinical Chemistry · 36
PDF
In Vitro Phase I Cytochrome P450 Metabolism, Permeability and Pharmacokinetics of SB639, a Novel Histone Deacetylase Inhibitor in Preclinical Species
2007 · Pilla Reddy Venkatesh, Evelyn Goh, et al. · Biological and Pharmaceutical Bulletin · 29
PDF
Diagnosing intake and rationalizing toxicities associated with 5F-MDMB-PINACA and 4F-MDMB-BINACA abuse
2020 · Wen Lie, Eleanor Jing Yi Cheong, et al. · Archives of Toxicology · 26
Preclinical Metabolism and Pharmacokinetics of SB1317 (TG02), a Potent CDK/JAK2/FLT3 Inhibitor
2012 · Mohammed Khalid Pasha, Ramesh Jayaraman, et al. · Drug Metabolism Letters · 26
Preclinical Metabolism and Disposition of SB939 (Pracinostat), an Orally Active Histone Deacetylase Inhibitor, and Prediction of Human Pharmacokinetics
2011 · Ramesh Jayaraman, Venkatesh Pilla Reddy, et al. · Drug Metabolism and Disposition · 25
A Rapid SPE-Based Analytical Method for UPLC/MS/MS Determination of Aminoglycoside Antibiotic Residues in Bovine Milk, Muscle, and Kidney
2014 · Michael S Young, Kim van Tran, et al. · Journal of AOAC International · 24
Qualitative Confirmation of 94 New Psychoactive Substances and Metabolites in Urine Using Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry
2023 · Evelyn Mei Ling Goh, Xue Qin Ng, et al. · Journal of Analytical Toxicology · 14
PDF
Identification of Optimal Urinary Biomarkers of Synthetic Cannabinoids BZO-HEXOXIZID, BZO-POXIZID, 5F-BZO-POXIZID, and BZO-CHMOXIZID for Illicit Abuse Monitoring
2022 · Keane Zhi Hao Lee, Ziteng Wang, et al. · Clinical Chemistry · 12
PDF
Transesterification of Indazole-3-carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarkers for Diagnosing Co-abuse of 5F-MDMB-PINACA and Alcohol
2021 · Ziteng Wang, Ching Yee Fong, et al. · Journal of Analytical Toxicology · 6
Elucidating the Phase I metabolism of psilocin in vitro
2025 · Junqi Chen, Ziteng Wang, et al. · Archives of Toxicology · 5
166 POSTER ADME and PK/PD attributes of SB939, a potent orally active HDAC inhibitor
2006 · K. Sangthongpitag, H. Wang, et al. · European Journal of Cancer Supplements · 4
Characterization of iso-LSD metabolism using human liver microsomes in comparison to LSD and its applicability as urinary biomarker for LSD consumption
2024 · Xue Qin Ng, Evelyn Mei Ling Goh, et al. · Journal of Analytical Toxicology · 3
Pharmacokinetic and Pharmacodynamic Properties of SB1317, a Potent and Orally Active Multi-Kinase Inhibitor.
2007 · Pauline Yeo, P. Venkatesh, et al. · Blood · 1
Delta-8-THC acetate-a prodrug of delta-8-THC?: A case report
2025 · Jonathan Wong, Evelyn Mei Ling Goh, et al. · Forensic Science International Reports
Metabolism of (-)-∆9-Tetrahydrocannabinol (THC) in Chicken and Potential Exposure of THC and Its Metabolites to Humans
2023 · Ziteng Wang, Chock Ying Soo, et al. · Journal of Pharmacology and Experimental Therapeutics
PDF
In vitro approaches for the identification and characterization of urinary metabolite biomarkers of synthetic cannabinoid ADB-BUTINACA
2022 · Evelyn Mei Ling Goh, Chi Hon Sia, et al. · Annales de Toxicologie Analytique
SB939: a potent, orally-active HDAC inhibitor for the treatment of haematologic malignancies and solid tumors
2007 · Kanda Sangthongpitag, Haishan Wang, et al. · Clinical Cancer Research
Works count: 18
Citation count: 250
H-index: 9
I10-index: 9
Year
Topic
Type